CARIBOU BIOSCIENCES INC
CRBU · NASDAQ
更新於 2026-10-15 08:28:24
- 今日最高
- $0.48
- 今日最低
- $0.44
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $0.47
- 昨天收盤價
- $0.46
- 成交量
- 3.7M
- 市值
- $49.32M
- 市盈率（P/E）
- --
- 每股收益（EPS）
- $-1.07
昨天價格區間
52週價格區間
公司概況
- 板塊
- 醫療保健
- 行業
- 生物科技
- 子行業
- 生物科技
- 總部
- 2929 7TH STREET, BERKELEY, CA, UNITED STATES, 94710
- 國家
- 美國
- 上市日期
- 2021-07-23
- 財年截止
- 十二月
- 流通股數
- 99.18M
- CIK
- 0001619856
Caribou Biosciences Inc. 是一家開創性的生物科技公司，專注於透過其專有 CRISPR 技術進行基因組編輯，旨在開發針對遺傳疾病和腫瘤學的變革性療法。憑藉強大且多元化的研發管道，應對重大未滿足的醫療需求，該公司處於引領精準醫療進展的有利位置。Caribou 的策略合作和對研究卓越的堅定承諾，支撐其革新治療範式、改善患者預後的使命，確立其在生物製藥領域關鍵參與者的地位。
財務指標
營業收入
2026-06-30
$1.49M
2026-03-31
$2.39M
2025-12-31
$3.94M
2025-09-30
$2.19M
營業支出
2026-06-30
$26.83M
2026-03-31
$28.02M
2025-12-31
$32.39M
2025-09-30
$9.19M
淨利潤
2026-06-30
-$24.28M
2026-03-31
-$25.08M
2025-12-31
-$26.48M
2025-09-30
-$27.54M
淨利潤率
2026-06-30
-1.61K%
2026-03-31
-1.04K%
2025-12-31
-672.11%
2025-09-30
-1.25K%
每股收益
2026-06-30
$-0.24
2026-03-31
$-0.26
2025-12-31
$-0.28
2025-09-30
$-0.30
息稅折舊攤銷前利潤
2026-06-30
-$25.77M
2026-03-31
-$24.43M
2025-12-31
-$26.35M
2025-09-30
-$26.91M
有效稅率
2026-06-30
--
2026-03-31
--
2025-12-31
2.03%
2025-09-30
--
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 營業收入 | $1.49M | $2.39M | $3.94M | $2.19M |
| 營業支出 | $26.83M | $28.02M | $32.39M | $9.19M |
| 淨利潤 | -$24.28M | -$25.08M | -$26.48M | -$27.54M |
| 淨利潤率 | -1.61K% | -1.04K% | -672.11% | -1.25K% |
| 每股收益 | $-0.24 | $-0.26 | $-0.28 | $-0.30 |
| 息稅折舊攤銷前利潤 | -$25.77M | -$24.43M | -$26.35M | -$26.91M |
| 有效稅率 | -- | -- | 2.03% | -- |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。